Curia and Replicate Bioscience enter strategic collaboration to create development platform for self-replicating RNA
June 21, 2022 – Curia and Replicate Bioscience, a company pioneering ways to prevent drug resistance in cancer and to treat autoimmune and inflammatory disorders…